SCHEMBL29974045

SCHEMBL29974045

O=CN1CCN(c2ccccn2)CC1

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PLD1 Q13393 1/20 0.58
▸ KDM4E B2RXH2 10/20 0.57
▸ ALDH1A1 P00352 7/20 0.57
▸ MAPT P10636 1/20 0.57
▸ HSD17B10 Q99714 3/20 0.56
▸ HPGD P15428 2/20 0.56
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ GAA P10253 1/20 0.54
▸ RAB9A P51151 1/20 0.54
▸ CYP3A4 P08684 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ RECQL P46063 1/20 0.51
▸ ADRB2 P07550 1/20 0.51
▸ LMNA P02545 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3258812 1.00 PLD1 (0.58) PLD1KDM4EALDH1A1MAPTHSD17B10
Hydrochloric Acid SCHEMBL20337933 0.98 PLD1 (0.56) PLD1KDM4EALDH1A1MAPTHSD17B10
SCHEMBL28434892 0.95 PLD1 (0.53) PLD1KDM4EALDH1A1MAPTHSD17B10
SCHEMBL29857922 0.86 PLD1 (0.73) PLD1KDM4EALDH1A1MAPTHSD17B10
SCHEMBL21353591 0.86 — —
SCHEMBL15800694 0.86 PLD1 (0.73) PLD1KDM4EALDH1A1MAPTHSD17B10
SCHEMBL25561240 0.80 ALDH1A1 (0.61) PLD1ALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL27580597 0.80 ALDH1A1 (0.82) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2
SCHEMBL4002258 0.80 KDM4E (0.55) PLD1KDM4EALDH1A1MAPTHSD17B10
SCHEMBL14562620 0.80 ALDH1A1 (0.64) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3307067-B1 AMINOPYRAZINE COMPOUNDS WITH A2A ANTAGONIST PROPERTIES MERCK SHARP & DOHME LLC (US) 2022-11-02 — — EP claimed
WO-2024131265-A1 COMPOUND FOR TREATING PI3Kγ-MEDIATED DISEASES AND USE THEREOF 中国科学院合肥物质科学研究院 2024-06-27 — — WO disclosed
Send feedback